{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:18:41Z","timestamp":1764645521967,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.4158\/accr-2020-0354","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T10:51:45Z","timestamp":1596711105000},"page":"e300-e304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Follow Up and Treatment Outcomes of A 2 Year-Old-Boy With Metastatic Testosterone-Secreting Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Danielle","family":"LoGiurato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Antal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2020-0354_bb0010","first-page":"2027","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0354_bb0015","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0354_bb0020","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1590\/S0100-879X2000001000008","article-title":"Clinical results of the use of mitotane for adrenocortical carcinoma","volume":"33","author":"Kasperlik-Zaluska","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"10.4158\/ACCR-2020-0354_bb0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2265.1987.tb01171.x","article-title":"The effect of o,p\u2019-DDD on adrenal steroid replacement therapy requirements","volume":"27","author":"Robinson","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/ACCR-2020-0354_bb0030","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors","volume":"93","author":"Almeida","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0354_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.mph.0000212965.52759.1c","article-title":"Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression","volume":"28","author":"Zancanella","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.4158\/ACCR-2020-0354_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.2012-2851","article-title":"Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5\u03b1-reductase, explaining the need for personalized glucocorticoid and androgen replacement","volume":"98","author":"Chortis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2020-0354_bb0045","first-page":"18","article-title":"Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor","volume":"2018","author":"Oddie","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.4158\/ACCR-2020-0354_bb0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2004-814563","article-title":"Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis","volume":"36","author":"Fottner","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.4158\/ACCR-2020-0354_bb0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-2007-978945","article-title":"Expression of insulin-like growth factor binding protein 1\u20136 genes in adrenocortical tumors and pheochromocytomas","volume":"30","author":"Ilvesm\u00e4ki","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.4158\/ACCR-2020-0354_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/eje.0.1440029","article-title":"Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors","volume":"144","author":"Boulle","year":"2001","journal-title":"Eur J Endocrinol"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060520306398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:56Z","timestamp":1762497116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060520306398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2376060520306398"],"URL":"https:\/\/doi.org\/10.4158\/accr-2020-0354","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Follow Up and Treatment Outcomes of A 2 Year-Old-Boy With Metastatic Testosterone-Secreting Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2020-0354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}